Updated
Updated · TODAY · Jul 8
FDA Approves Bemotrizinol Sunscreen Ingredient, Expanding UVA Protection in the U.S.
Updated
Updated · TODAY · Jul 8

FDA Approves Bemotrizinol Sunscreen Ingredient, Expanding UVA Protection in the U.S.

3 articles · Updated · TODAY · Jul 8

Summary

  • Bemotrizinol has won U.S. FDA approval, giving sunscreen makers a new ingredient that offers broader UVA coverage than current U.S. options.
  • Dermatologist Michelle Henry said the filter is also more photostable and less irritating, meaning it breaks down less in sunlight and may be easier for people to use consistently.
  • Henry said better sunscreen compliance matters because ultraviolet exposure is a risk factor for all major skin cancers, and she called dermatologists “over-the-moon excited” about the added option.
  • The approval comes as doctors urge regular skin checks for warning signs such as changing or ink-black moles, bleeding spots, dark nail streaks wider than 3 millimeters, pearly bumps and scaly patches.

Insights

Beyond the scalpel, can new immunotherapies and radiotherapy promise a scar-free future for skin cancer treatment?
As 3D body mapping and AI evolve, will they replace the dermatologist's eye for routine skin cancer checks?
If skin cancer is written in your DNA, can genetic testing offer a personalized roadmap to prevention?